Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4543)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 26, 2022 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pollard CM, Suster MS, Cora N, Carbone AM, Lymperopoulos A. GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone. World J Cardiol 2022; 14(4): 220-230 [PMID: PMC9048278 DOI: 10.4330/wjc.v14.i4.220] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v14/i4/220.htm |
| Number | Citing Articles |
| 1 |
Lucas Salgado Rezende de Mendonça, Sergio Senar, Luana Lorena Moreira, José Antônio Silva Júnior, Moni Nader, Luciana Aparecida Campos, Ovidiu Constantin Baltatu. Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach. Computers in Biology and Medicine 2024; 171: 108124 doi: 10.1016/j.compbiomed.2024.108124
|
| 2 |
Jing Wang, Haojie Xue, Jinyu He, Li Deng, Julong Tian, Yang Jiang, Jian Feng. Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01466-x
|